Intensity Modulated Radiotherapy Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology 

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Intensity Modulated Radiotherapy Market 

5.1. COVID-19 Landscape: Intensity Modulated Radiotherapy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Intensity Modulated Radiotherapy Market, By IMRT Delivery Technique

8.1. Intensity Modulated Radiotherapy Market, by IMRT Delivery Technique

8.1.1. Step and shoot IMRT

8.1.1.1. Market Revenue and Forecast

8.1.2. Sliding window IMRT

8.1.2.1. Market Revenue and Forecast

8.1.3. Volumetric modulated arc therapy

8.1.3.1. Market Revenue and Forecast

8.1.4. Helical IMRT

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Intensity Modulated Radiotherapy Market, By System Component

9.1. Intensity Modulated Radiotherapy Market, by System Component

9.1.1. Linear accelerator system

9.1.1.1. Market Revenue and Forecast

9.1.2. Multileaf collimator

9.1.2.1. Market Revenue and Forecast

9.1.3. Treatment planning system

9.1.3.1. Market Revenue and Forecast

9.1.4. Imaging and image guidance system

9.1.4.1. Market Revenue and Forecast

9.1.5. Oncology information system

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global Intensity Modulated Radiotherapy Market, By Cancer Site 

10.1. Intensity Modulated Radiotherapy Market, by Cancer Site

10.1.1. Prostate cancer

10.1.1.1. Market Revenue and Forecast

10.1.2. Breast cancer

10.1.2.1. Market Revenue and Forecast

10.1.3. Head and neck cancer

10.1.3.1. Market Revenue and Forecast

10.1.4. Gynecological cancers

10.1.4.1. Market Revenue and Forecast

10.1.5. Lung cancer

10.1.5.1. Market Revenue and Forecast

10.1.6. Brain and CNS tumors

10.1.6.1. Market Revenue and Forecast

Chapter 11. Global Intensity Modulated Radiotherapy Market, By End User

11.1. Intensity Modulated Radiotherapy Market, by End User

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast

11.1.2. Specialty cancer centers

11.1.2.1. Market Revenue and Forecast

11.1.3. Ambulatory radiotherapy centers

11.1.3.1. Market Revenue and Forecast

Chapter 12. Global Intensity Modulated Radiotherapy Market, By Service Model

12.1. Intensity Modulated Radiotherapy Market, by Service Model

12.1.1. New system installation

12.1.1.1. Market Revenue and Forecast

12.1.2. Upgrade and replacement

12.1.2.1. Market Revenue and Forecast

12.1.3. Maintenance and service contracts

12.1.3.1. Market Revenue and Forecast

Chapter 13. Global Intensity Modulated Radiotherapy Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.1.2. Market Revenue and Forecast, by System Component

13.1.3. Market Revenue and Forecast, by Cancer Site

13.1.4. Market Revenue and Forecast, by End User

13.1.5. Market Revenue and Forecast, by Service Model

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.1.6.2. Market Revenue and Forecast, by System Component

13.1.6.3. Market Revenue and Forecast, by Cancer Site

13.1.6.4. Market Revenue and Forecast, by End User

13.1.6.5. Market Revenue and Forecast, by Service Model  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.1.7.2. Market Revenue and Forecast, by System Component

13.1.7.3. Market Revenue and Forecast, by Cancer Site

13.1.7.4. Market Revenue and Forecast, by End User

13.1.7.5. Market Revenue and Forecast, by Service Model

13.2. Europe

13.2.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.2.2. Market Revenue and Forecast, by System Component

13.2.3. Market Revenue and Forecast, by Cancer Site

13.2.4. Market Revenue and Forecast, by End User  

13.2.5. Market Revenue and Forecast, by Service Model  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.2.6.2. Market Revenue and Forecast, by System Component

13.2.6.3. Market Revenue and Forecast, by Cancer Site

13.2.7. Market Revenue and Forecast, by End User  

13.2.8. Market Revenue and Forecast, by Service Model  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.2.9.2. Market Revenue and Forecast, by System Component

13.2.9.3. Market Revenue and Forecast, by Cancer Site

13.2.10. Market Revenue and Forecast, by End User

13.2.11. Market Revenue and Forecast, by Service Model

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.2.12.2. Market Revenue and Forecast, by System Component

13.2.12.3. Market Revenue and Forecast, by Cancer Site

13.2.12.4. Market Revenue and Forecast, by End User

13.2.13. Market Revenue and Forecast, by Service Model

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.2.14.2. Market Revenue and Forecast, by System Component

13.2.14.3. Market Revenue and Forecast, by Cancer Site

13.2.14.4. Market Revenue and Forecast, by End User

13.2.15. Market Revenue and Forecast, by Service Model

13.3. APAC

13.3.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.3.2. Market Revenue and Forecast, by System Component

13.3.3. Market Revenue and Forecast, by Cancer Site

13.3.4. Market Revenue and Forecast, by End User

13.3.5. Market Revenue and Forecast, by Service Model

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.3.6.2. Market Revenue and Forecast, by System Component

13.3.6.3. Market Revenue and Forecast, by Cancer Site

13.3.6.4. Market Revenue and Forecast, by End User

13.3.7. Market Revenue and Forecast, by Service Model

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.3.8.2. Market Revenue and Forecast, by System Component

13.3.8.3. Market Revenue and Forecast, by Cancer Site

13.3.8.4. Market Revenue and Forecast, by End User

13.3.9. Market Revenue and Forecast, by Service Model

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.3.10.2. Market Revenue and Forecast, by System Component

13.3.10.3. Market Revenue and Forecast, by Cancer Site

13.3.10.4. Market Revenue and Forecast, by End User

13.3.10.5. Market Revenue and Forecast, by Service Model

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.3.11.2. Market Revenue and Forecast, by System Component

13.3.11.3. Market Revenue and Forecast, by Cancer Site

13.3.11.4. Market Revenue and Forecast, by End User

13.3.11.5. Market Revenue and Forecast, by Service Model

13.4. MEA

13.4.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.4.2. Market Revenue and Forecast, by System Component

13.4.3. Market Revenue and Forecast, by Cancer Site

13.4.4. Market Revenue and Forecast, by End User

13.4.5. Market Revenue and Forecast, by Service Model

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.4.6.2. Market Revenue and Forecast, by System Component

13.4.6.3. Market Revenue and Forecast, by Cancer Site

13.4.6.4. Market Revenue and Forecast, by End User

13.4.7. Market Revenue and Forecast, by Service Model

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.4.8.2. Market Revenue and Forecast, by System Component

13.4.8.3. Market Revenue and Forecast, by Cancer Site

13.4.8.4. Market Revenue and Forecast, by End User

13.4.9. Market Revenue and Forecast, by Service Model

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.4.10.2. Market Revenue and Forecast, by System Component

13.4.10.3. Market Revenue and Forecast, by Cancer Site

13.4.10.4. Market Revenue and Forecast, by End User

13.4.10.5. Market Revenue and Forecast, by Service Model

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.4.11.2. Market Revenue and Forecast, by System Component

13.4.11.3. Market Revenue and Forecast, by Cancer Site

13.4.11.4. Market Revenue and Forecast, by End User

13.4.11.5. Market Revenue and Forecast, by Service Model

13.5. Latin America

13.5.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.5.2. Market Revenue and Forecast, by System Component

13.5.3. Market Revenue and Forecast, by Cancer Site

13.5.4. Market Revenue and Forecast, by End User

13.5.5. Market Revenue and Forecast, by Service Model

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.5.6.2. Market Revenue and Forecast, by System Component

13.5.6.3. Market Revenue and Forecast, by Cancer Site

13.5.6.4. Market Revenue and Forecast, by End User

13.5.7. Market Revenue and Forecast, by Service Model

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by IMRT Delivery Technique

13.5.8.2. Market Revenue and Forecast, by System Component

13.5.8.3. Market Revenue and Forecast, by Cancer Site

13.5.8.4. Market Revenue and Forecast, by End User

13.5.8.5. Market Revenue and Forecast, by Service Model

Chapter 14. Company Profiles

14.1. Hitachi

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Accuray

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Elekta

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Varian Medical Systems

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. RaySearch Laboratories

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Ion Beam Applications (IBA)

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Brainlab

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Siemens Healthineers

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. GE HealthCare

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Canon Medical Systems

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms